Duchenne UK is pleased to announce a grant of US$615,056 to Catabasis Pharmaceuticals to study Edasalonexent, a new drug for DMD to be tested in non-ambulant boys. To find out more about the project please watch this film and read our news story:
We would like to thank our partner charities Joining Jack and Alex's Wish for supporting this project. We would also like to thank our family funds who have supported this project: Archie's March, Help Harry , Jack's Aim and Jacobi's Wish.
If you have any questions about the project please email support@duchenneuk.org
0 Comments